Bartlett & Co Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Bartlett & Co Wealth Management's MRNA Position: Q3 2026 in Review
Bartlett & Co Wealth Management increased its Moderna (MRNA) stake by 104% in Q3 2026, buying an estimated $18K and bringing the position to 327 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #693.
Bartlett & Co Wealth Management first reported a position in MRNA in Q1 2022 and has held it in 19 quarters since. The position peaked at $77.2K in Q4 2022. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Bartlett & Co Wealth Management held 327 shares of Moderna worth $63K as of Q3 2026.
- Bartlett & Co Wealth Management bought 167 Moderna shares in Q3 2026, an estimated $18K.
- Moderna made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q3 2026, its #693 holding.
- Bartlett & Co Wealth Management first reported a position in Moderna in Q1 2022 and has held it in 19 quarters since.
- Bartlett & Co Wealth Management's Moderna position peaked at $77.2K in Q4 2022.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.